Plasmodium falciparum merozoite surface protein 1 (MSP1): genotyping and humoral responses to allele-specific variants (Q46304216)

21 December 2017

title

Plasmodium falciparum merozoite surface protein 1 (MSP1): genotyping and humoral responses to allele-specific variants (English)

1 reference

21 December 2017

main subject

Plasmodium falciparum

0 references

6

Francine Ntoumi

1 reference

21 December 2017

Marie-Thérèse Ekala

1

1 reference

21 December 2017

Hélène Jouin

2

1 reference

21 December 2017

Faustin Lekoulou

3

1 reference

21 December 2017

Saadou Issifou

4

1 reference

21 December 2017

Odile Mercereau-Puijalon

5

1 reference

21 December 2017

publication date

1 January 2002

1 reference

21 December 2017

published in

Acta Tropica

1 reference

21 December 2017

volume

81

1 reference

21 December 2017

issue

1

1 reference

21 December 2017

page(s)

33-46

1 reference

21 December 2017

What is clinical malaria? Finding case definitions for field research in highly endemic areas

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2801%2900188-7

Analysis of multiple Plasmodium falciparum infections in Tanzanian children during the phase III trial of the malaria vaccine SPf66.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2801%2900188-7

Different genetic characteristics of Plasmodium falciparum isolates collected during successive clinical malaria episodes in Senegalese children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2801%2900188-7

A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2801%2900188-7

The major merozoite surface protein as a malaria vaccine target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2801%2900188-7

Mechanisms of defense against P. falciparum asexual blood stages in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2801%2900188-7

In vivo veritas : lessons from immunoglobulin transfer experiments in malaria patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2801%2900188-7

Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2801%2900188-7

In vivo and in vitro derived Palo Alto lines of Plasmodium falciparum are genetically unrelated

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2801%2900188-7

Target antigens for asexual malaria vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2801%2900188-7

Fixed, epitope-specific, cytophilic antibody response to the polymorphic block 2 domain of the Plasmodium falciparum merozoite surface antigen MSP-1 in humans living in a malaria-endemic area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2801%2900188-7

Merozoite surface antigen 1 and 2 genotypes and rosetting of Plasmodium falciparum in severe and mild malaria in Lambaréné, Gabon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2801%2900188-7

Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2801%2900188-7

Phase I trial of the SPf66 malaria vaccine in a malaria-experienced population in Southeast Asia

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0001-706X%2801%2900188-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0001-706X%2801%2900188-7

7 January 2021

Extensive genetic diversity of Plasmodium falciparum isolates collected from patients with severe malaria in Dakar, Senegal

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2801%2900188-7

Evidence for an age-dependent pyrogenic threshold of Plasmodium falciparum parasitemia in highly endemic populations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2801%2900188-7

Seasonal changes in the Plasmodium falciparum population in individuals and their relationship to clinical malaria: a longitudinal study in a Sudanese village.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2801%2900188-7

Human malaria parasites in continuous culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2801%2900188-7

A cohort study of Plasmodium falciparum diversity during the dry season in Ndiop, a Senegalese village with seasonal, mesoendemic malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2801%2900188-7

Human antibody response to the major merozoite surface antigen of Plasmodium falciparum is strain specific and short-lived

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2801%2900188-7

7 January 2021

Relationship between maternally derived anti-Plasmodium falciparum antibodies and risk of infection and disease in infants living in an area of Liberia, west Africa, in which malaria is highly endemic.

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2801%2900188-7

7 January 2021

Development of the human immune response against the major surface protein (gp190) of Plasmodium falciparum.

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2801%2900188-7

7 January 2021

A prospective study of the association between the human humoral immune response to Plasmodium falciparum blood stage antigen gp190 and control of malarial infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0001-706X%2801%2900188-7

7 January 2021

10.1016/S0001-706X(01)00188-7

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017